Commission Implementing Decision (EU) 2025/1708 [Commission Implementing Decision (EU) 2025/1708 of 29 July 2025 concerning certain emergency measures relating to infection with lumpy skin disease virus in France and repealing Implementing Decision (EU) 2025/1336 (OJ L, 2025/1708, 5.8.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1708/oj).] lays down certain emergency measures related to outbreaks of infection with lumpy skin disease virus in France. More particularly, Implementing Decision (EU) 2025/1708 provides for the establishment in France of a restricted zone comprising protection and surveillance zones, in accordance with Article 21 of Delegated Regulation (EU) 2020/687, as well as a vaccination zone in accordance with Part 1 of Annex IX to Commission Delegated Regulation (EU) 2023/361 [Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L 52, 20.2.2023, p. 1, ELI: http://data.europa.eu/eli/reg_del/2023/361/oj).]. In addition, Article 1 of Implementing Decision (EU) 2025/1708 provides that those protection and surveillance zones, as well as the vaccination zone, are to comprise at least the areas listed in the Annexes thereto, and the measures required to be applied in those zones are to be applied at least until the dates set out in those Annexes.
Recital 4, Decision_act (EU) 2025/2305
In forcesince 10 Nov 2025
- celex=32025D1336
- num:eu=2025/1336